
In medical treatment the intersection of pharmacology and patient safety is a critical area of concern. A particularly alarming scenario arises when patients on Monoamine Oxidase Inhibitors (MAOIs) for depression are inadvertently treated with certain antibiotics, such as Linezolid, leading